VICTOR L SCHUSTER, MD
Osteopathic Medicine at Blondell Ave, Bronx, NY
License number
New York 177262
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
2
1515 Blondell Ave STE. 220, Bronx, NY 10461
275 W 96Th St, New York, NY 10025
275 W 96Th St, New York, NY 10025
Phone
(718) 430-2906
(718) 430-8659 (Fax)
(718) 430-8659 (Fax)
Professional information
Victor L Schuster, Bronx NY
Specialties:
Internal Medicine, Nephrology
Work:
Montefiore Medical Center
1300 Morris Park Ave, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 Montefiore Med Park-General
1575 Blondell Ave, Bronx, NY 10461
1300 Morris Park Ave, Bronx, NY 10461 Montefiore Medical Center
1825 Eastchester Rd, Bronx, NY 10461 Montefiore Med Park-General
1575 Blondell Ave, Bronx, NY 10461
Education:
Washington University at St. Louis (1977)
Dr. Victor L Schuster - MD (Doctor of Medicine)
Hospitals:
1515 Blondell Ave STE 220, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
1515 Blondell Ave STE 220, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Montefiore Medical Center
111 East 210Th St, Bronx 10467
1515 Blondell Ave STE 220, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical Schools
Washington University St Louis
Graduated: 1977
Washington University St Louis
Graduated: 1977
Human Prostaglandin Transporter
US Patent:
5792851, Aug 11, 1998
Filed:
Sep 3, 1996
Appl. No.:
8/706936
Inventors:
Victor L. Schuster - New York NY
Run Lu - Bronx NY
Run Lu - Bronx NY
Assignee:
Albert Einstin College of Medicine of Yeshiva University, a Division of
Yeshiva University - Bronx NY
Yeshiva University - Bronx NY
International Classification:
C07H 2104, C07K 1628, C12N 1512
US Classification:
536 235
Abstract:
The present invention provides a purified and isolated nucleic acid encoding human prostaglandin transporter (hPGT). The present invention also provides a vector comprising a nucleic acid encoding human prostaglandin transporter (hPGT), a cell stably transformed with this vector, as well as a method for producing a recombinant, human prostaglandin transporter (hPGT). The present invention also provides a purified and isolated human prostaglandin transporter (hPGT), and an antibody immunoreactive with this protein. The present invention further provides a method for evaluating the uptake of a selected prostaglandin by cells expressing nucleic acid encoding human prostaglandin transporter (hPGT). Finally, the present invention provides a vector and an embryonic stem cell each of which comprises nucleic acid encoding a mutant human prostaglandin transporter (hPGT), a non-human transgenic animal whose germ and somatic cells contain nucleic acid encoding a mutant human prostaglandin transporter (hPGT) introduced into said animal, or an ancestor thereof, at an embryonic stage, as well as a method for producing the non-human, transgenic animal.
Prostaglandin Transporter Inhibitors
US Patent:
8227466, Jul 24, 2012
Filed:
May 15, 2007
Appl. No.:
12/227267
Inventors:
Victor L. Schuster - New York NY, US
Yuling Chi - Bronx NY, US
Young-Tae Chang - Singapore, SG
Jaeki Min - Marietta GA, US
Yuling Chi - Bronx NY, US
Young-Tae Chang - Singapore, SG
Jaeki Min - Marietta GA, US
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 31/53, C07D 251/54
US Classification:
514245, 544196
Abstract:
Provided are methods of inhibiting prostaglandin transporter (PGT) activity in mammals. Also provided are methods of determining whether a test compound is an inhibitor of a prostaglandin transporter. Additionally provided are compounds that inhibit prostaglandin transporter activity, and pharmaceutical compositions of those compounds. Methods of inhibiting COX-2 in a mammal are also provided. Additionally, methods of treating pain or inflammation in a mammal are provided.
Prostaglandin Transporter Inhibitors And Uses Thereof
US Patent:
2012023, Sep 20, 2012
Filed:
Sep 20, 2010
Appl. No.:
13/394857
Inventors:
Victor L. Schuster - New York NY, US
Yuling Chi - New Rochelle NY, US
Andrew S. Wasmuth - Brooklyn NY, US
Richard S. Pottorf - Belle Meade NJ, US
Gary L. Olson - Mountainside NJ, US
Yuling Chi - New Rochelle NY, US
Andrew S. Wasmuth - Brooklyn NY, US
Richard S. Pottorf - Belle Meade NJ, US
Gary L. Olson - Mountainside NJ, US
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 31/53, C07D 251/52, C07D 413/12, A61K 31/5377, C07D 401/12, C07D 409/12, C07D 403/12, A61P 19/02, A61P 29/00, A61P 9/12, A61P 27/06, A61P 17/02, A61P 15/04, A61P 15/00, A61P 1/00, A61P 11/00, A61P 11/06, A61P 25/28, A61P 37/08, A61P 35/00, A61P 1/04, A61P 7/02, A61P 7/06, A61P 19/06, A61P 19/00, A61P 19/10, A61P 9/10, A61P 9/00, A61P 9/04, A61P 25/00, A61P 25/16, A61P 25/06, A61P 37/00, A61P 25/02, A61P 25/24, A61P 27/02, A61P 21/04, A61P 35/04, A61P 7/04, A61P 15/06, A61P 31/04, A61P 33/02, C07D 251/54
US Classification:
5142362, 544197, 514245, 544208, 544113, 544198
Abstract:
Disclosed are compounds for inhibiting prostaglandin transporter (PGT) activity, pharmaceuticals compositions including the compounds, and methods of treating subjects using the compounds.
Prostaglandin Transporter Inhibitors
US Patent:
2013017, Jul 4, 2013
Filed:
Jul 23, 2012
Appl. No.:
13/555408
Inventors:
Victor L. Schuster - New York NY, US
Yuling Chi - Bronx NY, US
Young-Tae Chang - Singapore, SG
Jaeki Min - Marietta GA, US
Yuling Chi - Bronx NY, US
Young-Tae Chang - Singapore, SG
Jaeki Min - Marietta GA, US
International Classification:
A61K 31/53, G01N 33/68, A61K 31/713
US Classification:
4241721, 514245, 514 44 A, 514 44 R, 506 9, 435 721
Abstract:
The present invention generally relates to prostaglandin transport. More specifically, the invention is directed to compounds that inhibit prostaglandin transport and subsequent COX-2 induction, and methods relating thereto.